Literature DB >> 35389161

Ciliary and immune dysfunctions and their genetic background in patients with non-cystic fibrosis bronchiectasis in Central Iran.

Shakiba Hassanzadeh1, Somayeh Sadeghi1, Mahbube Jafari1, Somayeh Najafi1, Newsha Molavi1, Roya Sherkat2.   

Abstract

OBJECTIVE: Bronchiectasis is usually caused by recurrent bacterial infections and is characterized by irreversible dilation of the bronchi. In this study, we aimed to give an overview of the genetic backgrounds of patients with non-cystic fibrosis bronchiectasis (NCFB) that have been suspected to an underlying ciliary dysfunction or inborn error of immunity (IEI).
METHOD: This is a retrospective cross-sectional study. Seventy-one NCFB patients who were referred to the Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran, from 1996 to 2020 were included. These patients were referred to this center for immunological and genetic evaluation. Genetic analysis with whole-exome sequencing and Sanger sequencing was confirmed in 30 patients. However, the genetic evaluations of 41 patients were either still under evaluation or the patients had refused to be genetically evaluated. RESULT: Thirty-eight of our 71 patients (53.52%) were diagnosed with ciliary dysfunction and the detected mutations included mutations in the CCDC65, DNAH11, RSPH1, CCDC40, and GAS8 genes as well as a novel mutation. Thirty-three patients (46.47%) had an IEI and the detected mutations included mutations of the following genes: TNFRSF13B, PTPN2, ZNF341 BTK, TCF3, CD79a, PIK3CD, JAGN1, WAS, RFXANK, STK4, GSDMD, and NEMO.
CONCLUSION: This study presents an overview of the underlying ciliary and immune dysfunctions and their genetic mutations in NCFB in a highly consanguine population. This would give us a better understanding of the etiologies and the known and novel genetic mutations in NCFB in Iran and, in turn, in the Middle East and North Africa (MENA) region.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Ciliopathy; Immune system dysfunction; Inborn errors of immunity; Non-cystic fibrosis bronchiectasis; Whole-exome sequencing

Year:  2022        PMID: 35389161     DOI: 10.1007/s11845-022-02994-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  27 in total

1.  An investigation into causative factors in patients with bronchiectasis.

Authors:  M C Pasteur; S M Helliwell; S J Houghton; S C Webb; J E Foweraker; R A Coulden; C D Flower; D Bilton; M T Keogan
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  Update in Bronchiectasis 2014.

Authors:  Bravein Amalakuhan; Diego J Maselli; Miguel A Martinez-Garcia
Journal:  Am J Respir Crit Care Med       Date:  2015-11-15       Impact factor: 21.405

Review 3.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

Review 4.  Bronchiectasis--diagnosis and treatment.

Authors:  Jessica Rademacher; Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2011-12-02       Impact factor: 5.594

Review 5.  Aetiology of bronchiectasis in adults: A systematic literature review.

Authors:  Yong-Hua Gao; Wei-Jie Guan; Shao-Xia Liu; Lei Wang; Juan-Juan Cui; Rong-Chang Chen; Guo-Jun Zhang
Journal:  Respirology       Date:  2016-06-19       Impact factor: 6.424

Review 6.  Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.

Authors:  Pieter Goeminne; Lieven Dupont
Journal:  Postgrad Med J       Date:  2010-08       Impact factor: 2.401

Review 7.  Bronchiectasis.

Authors:  A F Barker
Journal:  Semin Thorac Cardiovasc Surg       Date:  1995-04

Review 8.  Genetic causes of bronchiectasis: primary immune deficiencies and the lung.

Authors:  Luigi D Notarangelo; Alessandro Plebani; Evelina Mazzolari; Annarosa Soresina; Maria Pia Bondioni
Journal:  Respiration       Date:  2007       Impact factor: 3.580

Review 9.  Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.

Authors:  James D Chalmers; Adam T Hill
Journal:  Mol Immunol       Date:  2012-10-22       Impact factor: 4.407

10.  Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

Authors:  Aziz Bousfiha; Leila Jeddane; Capucine Picard; Waleed Al-Herz; Fatima Ailal; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan; Stuart G Tangye
Journal:  J Clin Immunol       Date:  2020-02-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.